Skip to main content


Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

Fig. 1

Kaplan survival curve free for all cause deaths (upper part), and cardiac deaths (lower part) event in GLP-1 agonist users (blu color), and non GLP-1 agonist users (green color). p value > 0.05

Back to article page